Roy Bingham, CEO ofBDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly$46 billion by 2028.
This growth would be primarily fueled by the expansion of adult-use markets and adoption of new licensed and regulated markets, both medical and recreational. Key states driving this surge include New York, New Jersey and potentially Florida and Ohio, Bingham says.
Influence Of DEA Rescheduling
Following the DEA's decision to reclassify cannabis to Schedule III, Bingham predicts this will open up new avenues for medical research and investment. "We expect major medical discoveries within five years," he...
Login or create a forever free account to read this news
Sign up/Log in